Inhibition of neovascularization with a soluble chimeric protein comprising VEGF FLT-1 and KDR domains
    1.
    发明授权
    Inhibition of neovascularization with a soluble chimeric protein comprising VEGF FLT-1 and KDR domains 有权
    用包含VEGF FLT-1和KDR结构域的可溶性嵌合蛋白抑制新生血管形成

    公开(公告)号:US08216575B2

    公开(公告)日:2012-07-10

    申请号:US12457478

    申请日:2009-06-11

    申请人: Michael Dechao Yu

    发明人: Michael Dechao Yu

    IPC分类号: A61K38/18 C07K14/71 C12N15/62

    摘要: Described herein are novel soluble chimeric fusion proteins comprising amino acid sequences derived from the vascular endothelial growth factor (VEGF) receptors flt-1 and KDR, including domain 4 of KDR. The claimed chimeric fusion proteins antagonize the endothelial cell proliferative and angiogenic activity of VEGF and are useful in the treatment of neovascularization-related disease.

    摘要翻译: 本文描述的是包含衍生自血管内皮生长因子(VEGF)受体flt-1和KDR(包括KDR的结构域4)的氨基酸序列的新型可溶性嵌合融合蛋白。 所要求的嵌合融合蛋白拮抗VEGF的内皮细胞增殖和血管生成活性,并且可用于治疗新血管形成相关疾病。

    Adenovirus packaging cell lines
    6.
    发明申请
    Adenovirus packaging cell lines 审中-公开
    腺病毒包装细胞系

    公开(公告)号:US20070141706A1

    公开(公告)日:2007-06-21

    申请号:US11545917

    申请日:2006-10-11

    IPC分类号: C12N15/861 C12N5/10

    摘要: Adenovirus packaging cell lines for growth of an E1A/E1B deficient adenovirus that is substantially free of replication competent adenovirus (RCA) are provided. Methods for producing adenovirus substantially free of RCA are also provided, wherein the adenovirus is grown in a cell line containing coding sequences for adenovirus E1A and E1B, which are operably linked to promoters that lack polynucleotide sequences sharing substantial sequence identity with the native adenovirus E1A and E1B promoters.

    摘要翻译: 提供了基本上不含复制性腺病毒(RCA)的E1A / E1B缺陷型腺病毒生长的腺病毒包装细胞系。 还提供了用于产生基本上不含RCA的腺病毒的方法,其中腺病毒在含有腺病毒E1A和E1B编码序列的细胞系中生长,所述编码序列与腺病毒E1A和E1B的编码序列可操作地连接,所述编码序列与缺乏与天然腺病毒E1A具有实质序列同一性的多核苷酸序列的启动子连接, E1B启动子。